Top Story

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR
April 25, 2015

VIENNA — Howard Monsour, Jr., MD, chief of hepatology, Houston Methodist Hospital, Texas, discussed results of the C-SURFER trial, where 99% of patients with advanced chronic kidney disease treated with grazoprevir and elbasvir for chronic hepatitis C virus genotype 1 infection achieved sustained virologic response.

“This is a landmark trial in that it takes a group of patients who have essentially been left out of the fantastic discoveries for treatments of hepatitis C recently; those being patients with chronic kidney disease,” Monsour said.

Meeting News Coverage

C-SWIFT: 8 weeks of therapy may be possible with grazoprevir/elbasvir

April 25, 2015
VIENNA — Patients with cirrhosis as well as genotype 1 and genotype 3 HCV responded favorably to 8 weeks of treatment with a novel grazoprevir and elbasvir-based…
Chikungunya common among US volunteers in Dominican Republic Meeting News Coverage

Chikungunya common among US volunteers in Dominican Republic

April 24, 2015
Infection with chikungunya was common among a group of United States volunteers working in the Dominican Republic during a large outbreak there, according to recent…
Jonathan Mermin In the Journals

HIV infections surge in Indiana

April 24, 2015
INDIANA — Indiana Gov. Mike Pence issued a second 30-day public health disaster emergency today as state and federal health care agencies attempt to contain a…
Meeting News Coverage

EASL releases, outlines 2015 HCV recommendations

April 24, 2015
VIENNA — The goal of HCV therapy is to eradicate infection, according to Jean-Michel Pawlotsky, MD, PhD, Coordinator of the panel that published the 2015 EASL…
More News Headlines »
CME
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Monograph

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
Meeting News Coverage Video
VIDEO: Assessment of vaccine safety, efficacy critical after introduction

VIDEO: Assessment of vaccine safety, efficacy critical after introduction

April 21, 2015
BETHESDA, Md. — Kathleen M. Neuzil, MD, MPH, director of vaccine access and delivery at PATH in Seattle and…
More »
CME
Conjuctivitis

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

Acute bacterial conjunctivitis affects approximately 1 of every 8 children each year, and 5 million cases occur in the…
More »
morganatic-roan